1.35p+0.00 (+0.00%)28 Mar 2024, 15:44
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Iq-Ai Limited Fundamentals

Company NameIq-Ai LimitedLast Updated2024-03-28
IndustryHealth Information ServicesSectorHealthcare
Shares in Issue221.710 mMarket Cap£2.99 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS£-0.00EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio2.6803Cash Equity Ratio0.2168
Quick Ratio0.6375Current Ratio0.64
Price To Book Value7.1942ROCE0

Iq-Ai Limited Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Iq-Ai Limited Company Financials

Assets20222021
Tangible Assets£4,233.00£4,440.00
Intangible Assets£752,090.00£772,263.00
Investments00
Total Fixed Assets£756,323.00£776,703.00
Stocks00
Debtors£160,967.00£49,546.00
Cash & Equivalents£313,985.00£728,586.00
Other Assets00
Total Assets£1.27 m£1.58 m
Liabilities20222021
Creditors within 1 year£560,508.00£392,787.00
Creditors after 1 year00
Other Liabilities00
Total Liabilities£560,508.00£392,787.00
Net assets£707,073.00£1.19 m
Equity20222021
Called up share capital£1.83 m£1.83 m
Share Premium£20.58 m£20.57 m
Profit / Loss-£511,601.00-£501,058.00
Other Equity£707,073.00£1.19 m
Preference & Minorities00
Total Capital Employed£707,073.00£1.19 m
Ratios20222021
Debt Ratio00
Debt-to-Equity00
Assets / Equity2.68032.6803
Cash / Equity0.21680.2168
EPS£-0.00£-0.00
Cash Flow20222021
Cash from operating activities-£374,671.00-£288,759.00
Cashflow before financing-£374,671.00£306,241.00
Increase in Cash-£414,601.00£249,676.00
Income20222021
Turnover£535,886.00£521,069.00
Cost of sales£1,782.00£17,047.00
Gross Profit£534,104.00£504,022.00
Operating Profit-£500,891.00-£490,348.00
Pre-Tax profit-£511,601.00-£501,058.00

Iq-Ai Limited Company Background

SectorHealthcare
ActivitiesIQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on proven technologies.Its geographical segment includes Jersey and the United States of America and reportable segments are holding company expenses and medical software. The company derives a majority of revenue from the United States of America. It also supplies medical technology solutions and has a strong neuroimaging product portfolio.
Latest Interim Date17 Aug 2023
Latest Fiscal Year End Date26 Apr 2023

Iq-Ai Limited Directors

AppointedNamePosition
2016-05-06Mr. Stephen Sands CookExecutive Director,Chief Executive Officer and Company Secretary
2013-04-26Mr. John Henwood MBENon-Executive Director
2013-01-23Mr. Timothy Hugh Southcombe Trotter Non-Executive Director,Chairman
2013-04-30Mr. Paul R DavidsonNon-Executive Director,Chairman
2012-05-01Mr. Anthony GeeExecutive Director,Group Finance Director and Company sec
2013-04-26Mr. Gerald VoisinNon-Executive Director
2006-11-29Mr. Paul Ian FraserNon-Executive Director,Chairman
2011-08-09Mr. Mark Tristam Norwood DugdaleExecutive Director,Chief Executive
2011-08-09Mr. Graham Norton FCAExecutive Director,Finance Director and Company Secretary
2024-03-05Mr. Trevor Edward BrownExecutive Director,Chief Executive Officer
2024-03-05Mr. Vinod KaushalNon-Executive Director
2018-05-07Dr. Qu LiNon-Executive Director,Chairman
2024-03-05Mr. Michael SchmaindaNon-Executive Director
2024-03-05Mr. Brett SkellyNon-Executive Director

Iq-Ai Limited Contact Details

Company NameIQ-AI Ltd
AddressForum 4, Grenville Street, P. O. Box 264, St Helier, JE4 8TQ
Telephone
Websitehttps://www.imagingbiometrics.com

Iq-Ai Limited Advisors

SolicitorMJ Hudson
Phone+44 1534712900
RegistrarShare Registrars Limited
Phone+44 1252821390
Fax+44 1252719232
SolicitorCharles Russell Speechlys LLP
Phone+44 2072035000
StockbrokerPeterhouse Corporate Finance Ltd
Phone+44 2074690930
Fax+44 2072209798
Financial AdviserPeterhouse Corporate Finance Ltd
Phone+44 2074690930
Fax+44 2072209798
AuditorWelbeck Associates
Phone+44 2074671700
BankBarclays Bank PLC
Financial PR AdviserSmithfield Consultants
Phone+44 2030472000
AuditorDeloitte LLP